Immunoengineering Lab

Wilson Lab at Vanderbilt

[PhRMA Foundation @PhRMAfoundation]

Immunotherapy often fails b/c tumors “turn off” the immune system. #PhF26 awardee Dr. Anastasia Varanko @WilsonLabVU @VanderbiltU is engineering a targeted therapy that reprograms suppressive immune cells in tumors to instead attack #cancer. @AVaranko121

https://t.co/g2ZqEnjSQR

[Immunoengineering Lab @WilsonLabVU]

Huge congratulations to Dr. Ella Adjei-Sowah (@easa_me) on her @CancerResearch Postdoctoral Fellowship!

[Cancer Research Institute @CancerResearch]

The Cancer Research Institute is honored to share the Winter 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows. Meet this new class of visionaries, backed by CRI's urgent commitment to keep progress moving forward: https://t.co/cxJ2BZNnly #CancerResearch

[Cancer Research Institute @CancerResearch]

The Cancer Research Institute is honored to share the Winter 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows. Meet this new class of visionaries, backed by CRI's urgent commitment to keep progress moving forward: https://t.co/cxJ2BZNnly #CancerResearch

[Immunoengineering Lab @WilsonLabVU]

Congratulations to @AVaranko121 on being selected for a @PhRMAfoundation Fellowship to support her work on Treg-targeted immunotherapies!

[PhRMA Foundation @PhRMAfoundation]

The PhRMA Foundation is pleased to award 50 early-career researchers with a total of more than $3.6 million in 2026 #fellowships and #grants focused on #DrugDiscovery, #DrugDelivery, and #Translational medicine research.

View the #PhF26 awardees: https://t.co/hCzpmvQ6fI

[PhRMA Foundation @PhRMAfoundation]

The PhRMA Foundation is pleased to award 50 early-career researchers with a total of more than $3.6 million in 2026 #fellowships and #grants focused on #DrugDiscovery, #DrugDelivery, and #Translational medicine research.

View the #PhF26 awardees: https://t.co/hCzpmvQ6fI

[Immunoengineering Lab @WilsonLabVU]

This year I am riding with Clip in 4 the Cure to help raise funding to support cancer research. Please visit our team site at: https://t.co/TGeb0NQeVo and consider giving what you can to support the Vanderbilt-Ingram Cancer Center!

[J. Am. Chem. Soc. @J_A_C_S]

Macromolecular Diamidobenzimidazole Conjugates Can Activate Stimulator of Interferon Genes | Journal of the American Chemical Society @VanderbiltU https://t.co/poPWeySnTP

[Chris Rodell @ChrisRodell2]

Join us for #IMES2025!
🚨 The abstract deadline is approaching for trainees and early career PI's! Due: Aug. 15, 2025
📢 Travel scholarships are available for students and postdocs from underrepresented or disadvantaged backgrounds!
👉Learn more/submit: https://t.co/CMAPmBAJ2b

[VU Engineering @VUEngineering]

Researchers led by @VanderbiltU School of Engineering associate prof. John T. Wilson, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. Read more: https://t.co/A4DLT6Png0

[Nature Reviews Bioengineering @natrevbioeng]

Writing is thinking https://t.co/TdFGfkTPrI

[Immunoengineering Lab @WilsonLabVU]

@JinmingGaoLab Thanks, Jinming! Would love to chat with you sometime about your translational experience in this space.

[Immunoengineering Lab @WilsonLabVU]

Congrats to @WilsonLabVU @VanderbiltVinse graduate student Jack Loken on earning an @NSF GRFP award!!

[U.S. National Science Foundation @NSF]

Today, NSF announced an add’l 500 NSF Graduate Research Fellowship Program awardees for the 2025-2026 cohort, bringing the total to approx 1,500. #NSFGRFP supports grad students as they pursue their dreams, build STEM skills, & become the next generation of innovators & leaders.

[OncoDaily IO @OncoDailyIO]

Engineering a STING Agonist-Powered Immune Response with Nanobody Conjugates - Kimryn Rathmell
@NCIDirector | @BlaiseKimmel | @neil_chada

https://t.co/6JK0aHuenD

#OncoDaily #Oncology #Cancer #MedX #MedEd #NanobodyConjugates

[Immunoengineering Lab @WilsonLabVU]

@KimrynRathmell Thanks, Kim! Much appreciated and thank you and your group for all the help and support. Hope you are enjoying your new role @OSUCCC_James - they are lucky to have you!

[Immunoengineering Lab @WilsonLabVU]

Excited to share our latest publication in @natBME! Big congrats to all co-authors on this highly collaborative effort – especially to first author @BlaiseKimmel for his dedication to this project! Check out the paper (open access) here:

https://t.co/4n5arWCu9o

[Emily Day @TheDayLab]

The Cancer Nanotechnology Gordon Research Conference is just a few months away! Applications for the trainee-focused GRS are due by March 9 to be considered for an oral presentation. Hope to see you in Italy! https://t.co/2RnFVDmeMY

[Immunoengineering Lab @WilsonLabVU]

We are recruiting Postdoctoral Fellows to lead new projects focused on engineering of extracellular vesicles for drug delivery, gene editing, and immunotherapy for cancer and autoimmunity! Learn more about the position at https://t.co/UoHcG6LPij!

[Immunoengineering Lab @WilsonLabVU]

Congratulations to Dr. Lucinda Pastora and Dr. Taylor Sheehy!

[Immunoengineering Lab @WilsonLabVU]

Check out our @Nature News & Views perspective article an exciting new cancer vaccine technology.

[Nature News & Views @NatureNV]

This vaccine technology stimulates a killer T cell response in mouse models of cancer and SARS-CoV-2 infection

https://t.co/MdNv3bKFeL

[Duvall Lab @Duvall_Lab_VU]

@EdenTanner Next talking about turning ‘cold’ tumors ‘hot’ with targeted immunotherapy is Dr. Anya Varanko from @WilsonLabVU.